Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06790290 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Jun 2025 to Apr 3, 2025v4
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 420 to confirmed 421
    • Study completion date: Dec 2025 to Dec 2026
    • Site details revised at 3 of 3 sites
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2025 to Jan 27, 2025
    • Site details revised at 3 of 3 sites
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Phase 2 trial to evaluate safety and immunogenicity of Inventprise's (IVT) 25-valent pneumococcal conjugate vaccine (IVT PCV-25) in Healthy Infants
Trial Details
NCT Number NCT06790290
Lead Sponsor Inventprise Inc.
Collaborators: University of the Philippines-National Health Institute_Doña Nena Health Center, Health Index Multispecialty Clinic, Grand Centennial Homes Clinic
Conditions
(from sponsor)		 Pneumococcal Disease, Invasive
Related terms Pneumococcal Infections
Enrollment 421 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov